This public procurement record has 2 releases in its history.

Award

06 Aug 2020 at 01:00

Tender

16 Sep 2019 at 01:00

Summary of the contracting process

The University of Edinburgh is conducting a procurement process titled “Health Technology Consultancy Services - Commercialisation, Market Analysis and Design,” located in Edinburgh, UK. This open tender process, which involves the provision of consultancy services to support the Health Technology Accelerator Facility, is currently in the award stage with contracts signed on 13 June 2020. The tender covers various consultancy areas, including health technology commercialisation, market analysis, and design, with a total contract value of £1,100,000 and a submission deadline that has already passed as of 23 October 2019.

This tender presents significant opportunities for businesses, particularly small and medium-sized enterprises (SMEs) specialising in health technology, consultancy, and related fields. Companies that are experienced in market analysis, product design for healthcare applications, or technology commercialisation are ideally suited to engage in this procurement. The successful supply of these consultancy services could lead to additional contract renewals and further projects within the healthcare sector, thereby supporting business growth in an area with ongoing demand for innovation and expertise.

How relevant is this notice?

Notice Title

Heath Technology Consultancy Services - Commercialisation, Market Analysis and Design

Notice Description

The Health Technology Accelerator Facility requires the following types of specialist consultancy to assist with the development of the research projects that they fund. Specifically 1) Health Technology Commercialisation 2)Health Technology Market Analysis and 3) Heath Technology Design

Lot Information

Health Technology Commercialisation Consultancy Services

HTAF desires that, during the period in which they receive HTAF funding, the individual research project teams will map out a pathway by which their technology can be translated. An effective pathway must take into account many factors including, but not limited to, funding mechanisms, product development timelines, intellectual property, pathways to market and relevant regulatory pathways. The projects funded via HTAF concern a range of medical technologies across diverse disease areas. HTAF does not possess the in-house expertise to help the various project teams assemble effective commercialisation plans tailored to their specific project, and therefore wishes to employ the services of an external contractor to do so.

Renewal: 2 further 1 year extensions might be granted at the discretion of the University.

Health Technology Market Analysis Consultancy Services

There are a number of factors that preclude the successful translation/commercialisation of preclinical science. A common point of failure is the selection of the target market for the technology. A target market may be too small to be economically viable, may be well served by existing competing technologies or may possess several other barriers that would make adoption of the novel technology unlikely. HTAF therefore wishes the projects that it funds to obtain a thorough expert market assessment. HTAF does not possess the expertise to perform this analysis in-house, and therefore wishes to employ the services of an external contractor who can carry out a market assessment on the technologies currently being developed with HTAF funding.

Renewal: 2 further 1 year extensions might be granted at the discretion of the University.

Heath Technology Design Consultancy Services

A number of the projects supported by HTAF are concerned with the development of medical devices. In all cases, development is at a relatively early stage, with a technology readiness level (TRL) of between 2 & 4 (inclusive) as defined by the NIH Technology Readiness Guidelines - https://ncai.nhlbi.nih.gov/ncai/resources/techreadylevels. The devices may be aimed at a variety of clinical areas, and utilise a range of underlying technologies. The end user of said devices may range from patients themselves to highly specialised clinicians. Key to the development of a successful medical device (i.e. one that is adopted, used, and can benefit patients) is the design of the device itself. HTAF would like to engage the services of an external supplier who could help the HTAF-funded project teams consider device design from the very earliest stages of technical development. Details of specific deliverables are given below.

Renewal: 2 further 1 year extensions might be granted at the discretion of the University.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000595770
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG392173
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services


CPV Codes

73220000 - Development consultancy services

Notice Value(s)

Tender Value
£1,100,000 £1M-£10M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£370,000 £100K-£500K

Notice Dates

Publication Date
6 Aug 20206 years ago
Submission Deadline
23 Oct 2019Expired
Future Notice Date
Not specified
Award Date
13 Jun 20206 years ago
Contract Period
Not specified - Not specified
Recurrence
possibly dependent on funding

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
University Of Edinburgh
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH4 2XR
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM75 City of Edinburgh

Local Authority
City of Edinburgh
Electoral Ward
Inverleith
Westminster Constituency
Edinburgh West

Supplier Information

Number of Suppliers
6
Supplier Names

Bay Area Bioscience Center (dba CLSI)

Consard Limited

Design Partners

IP Pragmatics Limited

Riverway Consulting Ltd

True North Innovation

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP366524
    Heath Technology Consultancy Services - Commercialisation, Market Analysis and Design - The Health Technology Accelerator Facility requires the following types of specialist consultancy to assist with the development of the research projects that they fund. Specifically 1) Health Commercialisation 2)Health Market Analysis and 3) Heath Design
  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG392173
    Heath Technology Consultancy Services - Commercialisation, Market Analysis and Design - The Health Technology Accelerator Facility requires the following types of specialist consultancy to assist with the development of the research projects that they fund. Specifically 1) Health Technology Commercialisation 2)Health Technology Market Analysis and 3) Heath Technology Design

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...